28 articles for Z Liang
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors.

Georgia State University
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.

Beijing Pearl Biotech
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.

Beijing Pearl Biotech
The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.

Lexicon Pharmaceuticals
Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88.

Bristol-Myers Squibb
Synthesis and biological evaluation of 2-amino-5-aryl-3-benzylthiopyridine scaffold based potent c-Met inhibitors.

Chinese Academy of Sciences
Novel 5-(benzyloxy)pyridin-2(1H)-one derivatives as potent c-Met inhibitors.

Chinese Academy of Sciences
Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway.

Soochow University
Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation.

Georgia State University
Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients.

Hoffmann-La Roche
Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors.

Chinese Academy of Sciences
Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.

Emory University
Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.

Chinese Academy of Sciences
Identification and synthesis of N'-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase.

Chinese Academy of Sciences
Design, synthesis, and biological evaluation of novel highly selective non-carboxylic acid FABP1 inhibitors.

Guangdong Pharmaceutical University
Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation.

Chongqing Medical and Pharmaceutical College
Discovery of small molecule CXCR4 antagonists.

Emory University
Synthesis and bioactive evaluation of

Guangxi University
Discovery of Orally Bioavailable

China Pharmaceutical University
LXR-Mediated Regulation of Marine-Derived Piericidins Aggravates High-Cholesterol Diet-Induced Cholesterol Metabolism Disorder in Mice.

Southern Medical University
Dynamics of Post-Translational Modification Inspires Drug Design in the Kinase Family.

Soochow University
Ene-yne Hydroquinones from a Marine-derived Strain of the Fungus

Chinese Academy of Sciences
Exploring the Natural Piericidins as Anti-Renal Cell Carcinoma Agents Targeting Peroxiredoxin 1.

Chinese Academy of Sciences
Preliminary evaluation of fluoro-pegylated benzyloxybenzenes for quantification of β-amyloid plaques by positron emission tomography.

Beijing Normal University
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

Bristol-Myers Squibb
Prodrug amino acid derivative

Taisho Pharmaceutical
Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism.

Aristotle University of Thessaloniki
Mechanistic studies of inactivation of inducible nitric oxide synthase by amidines.

Northwestern University